Search PubMed⌕ Search

Biomedical subjects

S Stanley

Publications and source records attributed to S Stanley.

At least 55 records · Page 3Linked to original sources
PubMed1985

Hyperalimentation as cause of markedly worsened metabolic control in a patient with autoantibodies to the insulin receptor.

Patients with type B insulin resistance and acanthosis nigricans have autoantibodies to their insulin receptors and usually have signs and symptoms of other autoimmune diseases. The first case demonstrating that hyperalimentation markedly disturbs blood glucose control in type B insulin-resistant patients is described. Neither prednisone, insulin (up to 240 units per hour), nor tolbutamide appeared to help this patient's metabolic control. After the addition of cyclophosphamide for one week, the anti-insulin receptor autoantibody titer dropped from greater than 1:1,000 to 1:1. Six months later, the patient had a complete remission, which is rare, with only three other reported remissions in these patients with type B insulin resistance.

Acanthosis Nigricans↗
PubMed1983

Persistent visual hallucinations secondary to chronic solvent encephalopathy: case report and review of the literature.

A case of solvent encephalopathy presenting with persistent visual hallucinations, and characterised by a diffusely abnormal EEG and delayed visually evoked responses to checkerboard pattern reversal (VERs), is described. Abnormalities in the EEG and VERs showed minimal improvement over many months of abstinence from glue sniffing. The literature on the neurological sequelae of solvent abuse is reviewed.

Adolescent↗
PubMed1982

Drug abuse monitoring: a survey of solvent abuse in the county of Avon.

1 An attempt to identify the extent of solvent abuse in the County of Avon by means of a multidisciplinary reporting system is described. 2 Particular attention was given to identifying abusers thought to be most at risks. 3 Altogether 304 young persons involved in solvent abuse were identified within a 6-month period. The ages of the solvent abusers ranged from 9 to 21 years and 77% were aged between 14 and 17 years. 4 Thirty-nine of the sniffers were found to be solitary users and were thought to have multiple problems and possibly a poorer prognosis than the group sniffers. 5 The problems of confidentiality and inter-agency conflict are discussed.

Adolescent↗
PubMedDate not supplied

Morphine and etorphine: XIV. Detection by ELISA in equine urine.

We have raised antibodies to morphine and etorphine and developed one-step enzyme-linked immunosorbent assays (ELISA) for these drugs as part of a panel of post race tests for drugs in racing horses. These tests are simple, can be completed in 2 h, and can be read by visual inspection. The morphine ELISA has an I50 for morphine of about 1.5 ng/mL, while the etorphine ELISA has an I50 for etorphine of 250 pg/mL. Cross-reactivity studies show that the antimorphine antibody cross-reacts well with levorphanol, hydromorphone, and oxycodone, while the anti-etorphine antibody showed no cross-reactivity with buprenorphine, diprenorphine, oxymorphone, morphine, or thebaine. The morphine test readily detected parent morphine or its metabolites in equine urine for at least 8 h after administration of 50 mg/horse, while a 0.1 micrograms/kg dose of etorphine was detectable for up to 48 h post dosing. For each test the background activity in post-race urines was equal to or less than the I50 for the standard curves, making them useful equine forensic tests. Each of these tests has detected "positives" in post race urine samples and as such these tests are capable of substantially improving the speed and efficacy of both pre-race and post-race testing for morphine, etorphine, and their congeners in racing horses.

Animals↗
PubMedDate not supplied

Immunoassay detection of drugs in racing horses: detection of ethacrynic acid and bumetanide in equine urine by ELISA.

We have raised antibodies and developed one-step enzyme-linked immunosorbent assays (ELISA) for the diuretics ethacrynic acid and bumetanide as part of a panel of pre- and post-race tests for high potency drugs in racing horses. These ELISA tests are rapid (completed within one hour), sensitive, and can be read by eye. The ELISA detects ethacrynic acid at a drug concentration for half-maximal inhibition (I-50) of about 2.5 ng/mL for the parent drug. After dosing horses intravenously with 5 mg ethacrynic acid per horse, the parent drug or its metabolites are detectable in urine for at least 8 hours. The bumetanide ELISA has an I-50 for the parent drug of about 2.0 ng/mL and will detect bumetanide or its metabolites for about 8 hours in urine after intravenous administration of a 1.7-mg dose per horse. Both antibodies are relatively specific for each drug and do not cross-react with other commonly used diuretics or other acidic compounds often found in post-race equine urine samples. Ethacrynic acid and bumetanide are potent diuretics suspected of being illegally substituted for furosemide in certain racing jurisdictions. Development of these rapid, sensitive, and simple tests for these agents will allow more effective pre- and post-race control of the use of these agents in racing horses. Both tests have recently uncovered several "positives" for these medications in a midwestern racing jurisdiction.

Animals↗
PubMedDate not supplied

The heat is on.

Explore the source record for details and available documents.

Child↗